Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Shire    SHP   JE00B2QKY057

SHIRE

(SHP)
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
More Financials
Company
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on SHIRE
05/16TAKEDA PHARMACEUTICAL : Bracing for 383-B.-Yen Net Loss for FY 2019
AQ
05/14TAKEDA PHARMACEUTICAL : expects net loss in FY 2019 due to Shire buyout cost
AQ
04/26TAKEDA PHARMACEUTICAL : Revised Forecast of Consolidated Financials for FY2018
AQ
02/18TAKEDA PHARMACEUTICAL : Notice Regarding Issue of Hybrid Bonds to replace Senior..
AQ
02/15SHIRE : Annual results
CO
02/08Kamada Announces Additional Interim Results from Phase 2 Proof of Concept Cli..
AQ
01/18Alder BioPharmaceuticals Appoints Paul Streck, M.D. Chief Medical Officer
AQ
01/18Alder BioPharmaceuticals Appoints Paul Streck, M.D. Chief Medical Officer
AQ
01/14TAKEDA PHARMACEUTICAL : Shire and SAIIDAC announce planned delisting of notes fr..
AQ
01/11SHIRE PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
More news
Analyst Recommendations on SHIRE
More recommendations
Sector news : Pharmaceuticals - NEC
07:51aABBVIE : Nears Deal to Buy Allergan for More Than $60 Billion--3rd Update
DJ
07:42aGlobal Stocks Waver as Gold and Bitcoin Soar
DJ
07:39aAbbVie to buy Botox-maker Allergan in $63 billion deal
RE
07:35aAbbVie to buy Botox-maker Allergan in $63 billion deal
RE
07:20aABBVIE : Nears Deal to Buy Allergan for More Than $60 Billion--2nd Update
DJ
More sector news : Pharmaceuticals - NEC
Chart SHIRE
Duration : Period :
Shire Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target -100%
EPS Revisions
Managers
NameTitle
Howard Mayer Chief Medical Officer
Matthew Walker Head-Technical Operations
Andreas Eugen Busch Chief Scientific Officer
Amitabh Singh Director
Susan O’Reilly Secretary & Director
Sector and Competitors
1st jan.Capitalization (M$)
SHIRE0.00%0
JOHNSON & JOHNSON10.10%348 981
PFIZER0.05%233 072
ROCHE HOLDING LTD.13.50%227 848
NOVARTIS21.44%220 893
MERCK AND COMPANY11.91%206 641